Cumulus Neuroscience Announces Publication in Scientific Reports Demonstrating NeuLogiq Platform's Feasibility for At-Home Cognitive Assessment in ALS and FTD

Summary

Cumulus Neuroscience has announced the publication of the CNS-102 study results in Scientific Reports, demonstrating the feasibility and usability of its NeuLogiq Platform for at-home, multimodal cognitive assessment in individuals with ALS and FTD. The study showed high usability ratings, even for patients with significant motor and cognitive impairment. This marks the first published study to combine at-home EEG and multi-domain cognitive assessment in this patient population, addressing a critical measurement gap.